Uncategorized

UQ and CEPI partner with CSL to advance COVID-19 vaccine A landmark partnership will help to accelerate the future development, manufacture and distribution of a University of Queensland COVID-19 vaccine. Key points: Global biotechnology company CSL will further develop, manufacture and distribute UQ’s COVID-19 vaccine candidate. The UQ vaccine is expected to be available in…

The University of Queensland is the only Australian organisation tasked by the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine against the novel coronavirus. Funding received by government and philanthropic partners is an important extension of CEPI’s ongoing financial support. Donations could help reduce the timeline for an effective vaccine for COVID-19 by six months and advance vaccine…

Researchers have identified a promising new drug combination that could significantly help the immune system target cancer cells and kill them. The study published in Cell, describes a treatment that works by combining an intravenous dosage of a well known anti-nausea drug, prochlorperazine (called Stemetil in Australia), with existing cancer treatments. University of Queensland scientist Associate Professor…

Three University of Queensland lecturers who made a compelling crime film to engage students in their psychology course have been named the Australian University Teachers of the Year. The creative approach by Professor Blake McKimmie, Professor Barbara Masser and Professor Mark Horswill transformed their students’ learning experience, resulting in improved class attendance, quiz scores and knowledge…

A University of Queensland team has met a key milestone in their fast-tracked research to develop a vaccine for the coronavirus, COVID-19. In just three weeks, the team of researchers has created their first vaccine candidate in the laboratory and will move immediately into further development before formal pre-clinical testing. The proof-of-concept milestone comes after the project’s…

University of Queensland alumnus Dr Nigel Greenwood has been globally recognised for building the world’s first genuinely machine-intelligent artificial pancreas. The leader of Team MachineGenes, and founder of its member AI startups, is now one of the world’s 10 semifinalists in a global challenge to build AI applications to address critical global issues. The team…